Citing continued strong sales, Hitachi Medical Systems Americahas announced plans to establish an MRI research and developmentlaboratory at its U.S. headquarters in Twinsburg, OH. The group will develop new technologies, advanced clinicalapplications,
Citing continued strong sales, Hitachi Medical Systems Americahas announced plans to establish an MRI research and developmentlaboratory at its U.S. headquarters in Twinsburg, OH.
The group will develop new technologies, advanced clinicalapplications, and hardware and software enhancements, accordingto Sheldon Schaffer, HMSA vice president of marketing. Researchwill involve superconducting and permanent magnet technologies.
The company will recruit five engineers to staff the new facility,which will complement Hitachi's existing R&D operations inJapan.
HMSA, a joint venture between Hitachi and Summit World Trade,sells Hitachi MRI systems in the U.S.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.